World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 115 4440 4164 2420 2241 502 72506

Zachary Goodman publications per year

The chart shows the history of publications by Zachary Goodman between 1977 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Zachary Goodman published across 49 years, from 1977 to 2025, averaging 10.6 papers a year. Output peaked at 35 publications in 2018. 13 of the 518 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1977 to 2025. Vertical axis: number of publications, 0 to 35. Peak 35 publications in 2018. 1977: 3 publications 1978: 0 publications 1979: 2 publications 1980: 1 publication 1981: 2 publications 1982: 1 publication 1983: 0 publications 1984: 1 publication 1985: 5 publications 1986: 6 publications 1987: 2 publications 1988: 3 publications 1989: 4 publications 1990: 4 publications 1991: 4 publications 1992: 7 publications 1993: 2 publications 1994: 6 publications 1995: 6 publications 1996: 4 publications 1997: 2 publications 1998: 5 publications 1999: 5 publications 2000: 5 publications 2001: 9 publications 2002: 10 publications 2003: 17 publications 2004: 5 publications 2005: 9 publications 2006: 12 publications 2007: 17 publications 2008: 18 publications 2009: 14 publications 2010: 24 publications 2011: 25 publications 2012: 14 publications 2013: 17 publications 2014: 17 publications 2015: 21 publications 2016: 24 publications 2017: 31 publications 2018: 35 publications 2019: 27 publications 2020: 33 publications 2021: 23 publications 2022: 12 publications 2023: 11 publications 2024: 9 publications 2025: 4 publications
1977 2025

518 publications in total across all disciplines

View publications per year as a table
Zachary Goodman: publications per year, 1977 to 2025
Year Publications
1977 3
1978 0
1979 2
1980 1
1981 2
1982 1
1983 0
1984 1
1985 5
1986 6
1987 2
1988 3
1989 4
1990 4
1991 4
1992 7
1993 2
1994 6
1995 6
1996 4
1997 2
1998 5
1999 5
2000 5
2001 9
2002 10
2003 17
2004 5
2005 9
2006 12
2007 17
2008 18
2009 14
2010 24
2011 25
2012 14
2013 17
2014 17
2015 21
2016 24
2017 31
2018 35
2019 27
2020 33
2021 23
2022 12
2023 11
2024 9
2025 4
Total 518
Download as CSV

Zachary Goodman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Zachary Goodman sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 501–520 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 502 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617 502
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Zachary Goodman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Zachary Goodman sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 114–115 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393 115
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Zachary Goodman is affiliated with Inova Fairfax Hospital in the United States. Their primary field of study is Medicine, with a significant focus on Hepatology. Their research contributions span various subfields including Hepatology, Epidemiology, Surgery, Endocrinology, Diabetes and Metabolism, and Cell Biology.

The scientist's main research topics include:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Liver physiology and pathology
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Diet, Metabolism, and Disease

Zachary Goodman has published extensively in several high-impact journals. Their frequent publication venues are:

  • Journal of Hepatology (33 publications)
  • Hepatology (9 publications)
  • Gastroenterology (6 publications)
  • Hepatology Communications (5 publications)
  • Clinical Gastroenterology and Hepatology (4 publications)

Among recent papers authored or co-authored by Goodman, notable works include:

  • "Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials" (2020), published in Journal of Hepatology
  • "From NAFLD to MAFLD: Implications of a Premature Change in Terminology" (2020), published in Hepatology
  • "Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study" (2020), published in Hepatology
  • "Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH" (2020), published in Hepatology
  • "A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH" (2021), published in Hepatology

Collaborations feature prominently in Goodman's research activity. Frequent co-authors include:

  • Stephen A. Harrison
  • Zobair M. Younossi
  • Arun J. Sanyal
  • Quentin M. Anstee
  • Rohit Loomba

Best Publications

  • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

    Michael P. Manns;John G. McHutchison;Stuart C. Gordon;Vinod K. Rustgi

  • Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

    John G. Mchutchison;Stuart C. Gordon;Eugene R. Schiff;Mitchell L. Shiffman

  • Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

    Bruce R. Bacon;Stuart C. Gordon;Eric Lawitz;Patrick Marcellin

  • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

    Ting Tsung Chang;Robert G. Gish;Robert De Man;Adrian Gadano

  • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

    Patrick Marcellin;Ting Tsung Chang;Seng Gee Lim;Myron J. Tong

  • Lamivudine as initial treatment for chronic hepatitis B in the United States.

    Jules L. Dienstag;Eugene R. Schiff;Teresa L. Wright;Robert P. Perrillo

  • Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

    Ching Lung Lai;Daniel Shouval;Anna S. Lok;Ting Tsung Chang

  • Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

    Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo

  • Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Persistence of cccDNA During the Natural History of Chronic Hepatitis B and Decline During Adefovir Dipivoxil Therapy

    Bettina Werle-Lapostolle;Scott Bowden;Stephen Locarnini;Karsten Wursthorn;Karsten Wursthorn

  • Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

    Ting Tsung Chang;Yun Fan Liaw;Shun Sheng Wu;Eugene Schiff

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting–Tsung Chang

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia

    Masamichi Kojiro;Ian R. Wanless;Venancio Alves;Sunil Badve

  • Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

    Thierry Poynard;Vlad Ratziu;Frédéric Charlotte;Zachary Goodman

  • Grading and staging systems for inflammation and fibrosis in chronic liver diseases

    Zachary D. Goodman

  • A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

    Karen L. Lindsay;Christian Trepo;Tobias Heintges;Mitchell L. Shiffman

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement.

    Richard G. Barr;Giovanna Ferraioli;Mark L. Palmeri;Zachary D. Goodman

  • Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

    Adrian M. di Bisceglie;Zachary D. Goodman;Kamal G. Ishak;Jay H. Hoofnagle

Frequent Co-Authors

Zobair M. Younossi
Zobair M. Younossi Inova Health System
Rohit Loomba
Rohit Loomba University of California, San Diego
Andrew J. Muir
Andrew J. Muir Duke University
Stephen H. Caldwell
Stephen H. Caldwell University of Virginia
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Kamal G. Ishak
Kamal G. Ishak Armed Forces Institute of Pathology
Quentin M. Anstee
Quentin M. Anstee Newcastle University
John G. McHutchison
John G. McHutchison Duke University
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean becoming a physician. Today, online programs open new doors across health fields, offering flexibility for students balancing work and family. For example, those interested in medical administration can pursue a healthcare administration degree to train for leadership roles within hospitals, clinics, and insurance companies.

If you are looking for alternatives to medical practice itself, consider programs specializing in vital support roles—like enrolling in accredited medical billing and coding schools with financial aid. This pathway can lead to a rewarding career in health information management, often without years of schooling or major exams.

For aspiring nurses, the admissions process might be easier than expected. Some schools no longer require standardized pre-admission testing. Learn more by asking: do you have to take the teas test to get into nursing school? This option can streamline your journey into the nursing profession.

Already a registered nurse? Fast-track your advancement with asn to fnp programs, which bridge associate’s degree nurses to a Master’s and prepare you to become a Family Nurse Practitioner.

Best Scientists Citing Zachary Goodman

Trending Scientists

Recently Published Articles